In the past decade the importance of the vascular endothelium in cardiovascular pathophysiology has become more apparent.
It has long been recognised that abnormalities in the blood vessel wall, blood flow, and blood constituents may increase the tendency for thrombus to form (Virchow's triad). However, it is now apparent that the process of thrombus formation (thrombogenesis) requires complex interactions involving endothelial injury; platelet adherence, aggregation, and release; thrombin generation; and fibrin formation. 1 We are increasingly aware that the vascular endothelium is involved in the production of many substances that are intimately associated with the regulation of vessel tone and permeability, haemostasis, fibrinolysis, and synthesis of growth factors. The release of substances inhibiting contraction (for example, endothelial derived relaxing factor or EDRF) and platelet activation are examples of protective mechanisms that maintain normal blood pressure and cardiovascular haemodynamics.
Another substance, von Willebrand factor (vWF), is synthesised by and stored in endothelial cells. It seems to be important in mediating platelet aggregation and adhesion to the vascular endothelium and subendothehium.2 Because vWF release increases when endothelial cells are damaged, the concentration of vWF has been proposed as an indicator of endothelial disturbance or dysfunction.3
The availability of such an index of endothelial dysfunction may have clinical value because measurement of such a marker can be a noninvasive way of assisting in diagnosis or as an indicator of disease progression (table 1) . Endothelial dysfunction is, of course, important because this can change the ability of the cell to participate adequately in both coagulation and fibrinolysis; these changes may predispose to thrombus and atherosclerosis formation.1 3 Ischaemic heart disease The association between vWF concentrations and ischaemic heart disease is well recognised. There is an association between vWF and the clinical severity of angina, indicating a role for endothelial dysfunction in the pathogenesis of coronary artery disease, and changes in vWF concentrations with acute myocardial infarction have been found. The mechanism for this release of vWF in acute myocardial infarction may be related to the generation of free radicals that follows myocardial infarction and The precise mechanism by which vWF increases risk in patients with ischaemic heart disease remains unknown. Because of the role of vWF in both adhesion and aggregation of platelets and in coagulation, the increased concentrations of vWF may increase the risk of thrombus formation in patients with preexisting disease of the vascular wall, such as coronary artery disease, and thus lead to further reinfarctions. Alternatively, increasing endothelial damage in coronary artery disease may result in increased thrombin generation, resulting in higher concentrations of vWF.
Left ventricular dysfunction In a study of patients with ischaemic heart disease and cardiac dysfunction (as defined by radionuclide ventriculography) those with left ventricular aneurysms had the highest concentrations of plasma vWF.'0 This may be explained by two possible mechanisms. Firstly, these patients seem to have the greatest endothelial dysfunction (as reflected by vWF concentrations), potentially leading to the most intravascular thrombogenesis (this is consistent with the high plasma concentrations of D-dimer being found in these patients). Secondly, patients with the highest vWF concentrations have the greatest cardiovascular risk and consequently these patients may sustain the largest myocardial infarctions, or recurrent infarctions,7 resulting in the most cardiac "damage" and subsequent aneurysm formation.
Traditionally, heart failure has been regarded as being caused by abnormalities in the systolic or contractile function of the heart. However, 30-40% of patients with congestive heart failure have normal systolic function. Endothelial dysfunction may thus be related to abnormalities of diastolic function seen in ischaemic heart disease. However, in a Doppler echocardiographic study of 106 patients with ischaemic heart disease, there were no significant differences in vWF concentrations between patients with and without diastolic dysfunction."
Atrial fibrillation
The risk of stroke and thromboembolism is increased in atrial fibrillation. In a cross sectional study of 85 The precise mechanism for the increase in vWF in cardiovascular disorders remains uncertain, although a cytokine-mediated increase in synthesis is likely to be the common pathway. 
